Zhaoshi Bai

995 total citations
30 papers, 818 citations indexed

About

Zhaoshi Bai is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Zhaoshi Bai has authored 30 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Zhaoshi Bai's work include Synthesis and biological activity (9 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Cancer Mechanisms and Therapy (4 papers). Zhaoshi Bai is often cited by papers focused on Synthesis and biological activity (9 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Cancer Mechanisms and Therapy (4 papers). Zhaoshi Bai collaborates with scholars based in China and United States. Zhaoshi Bai's co-authors include Weige Zhang, Jingwen Xu, Huan Qi, Yingliang Wu, Kai Bao, Daiying Zuo, Xuewei Jiang, Lingman Ma, Qi Guan and Weihua Jiang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Nanoscale and RSC Advances.

In The Last Decade

Zhaoshi Bai

29 papers receiving 816 citations

Peers

Zhaoshi Bai
Maha Abdulla Saudi Arabia
Arindam Talukdar India
Dipon Das India
Dejene Tolossa Debela Ethiopia
Merve Erkısa Türkiye
Praveen Sharma India
Yongsheng Xie China
Salomão Dória Jorge Brazil
Yasuyo Suga Japan
Matthew L. Brown United States
Maha Abdulla Saudi Arabia
Zhaoshi Bai
Citations per year, relative to Zhaoshi Bai Zhaoshi Bai (= 1×) peers Maha Abdulla

Countries citing papers authored by Zhaoshi Bai

Since Specialization
Citations

This map shows the geographic impact of Zhaoshi Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaoshi Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaoshi Bai more than expected).

Fields of papers citing papers by Zhaoshi Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaoshi Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaoshi Bai. The network helps show where Zhaoshi Bai may publish in the future.

Co-authorship network of co-authors of Zhaoshi Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaoshi Bai. A scholar is included among the top collaborators of Zhaoshi Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaoshi Bai. Zhaoshi Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bai, Zhaoshi, Yupeng Li, Yuejiao Zhong, et al.. (2024). Inhibiting autophagy enhanced mitotic catastrophe-mediated anticancer immune responses by regulating the cGAS-STING pathway. Cancer Letters. 586. 216695–216695. 6 indexed citations
3.
Ye, Xinyue, Pengfei Xu, Xiaoqian Yang, et al.. (2023). Peptide MSI ‐1 inhibited MCR ‐1 and regulated outer membrane vesicles to combat immune evasion of Escherichia coli. Microbial Biotechnology. 16(9). 1755–1773. 6 indexed citations
4.
5.
Liu, Xiaobo, Yuzhen Li, Qian Zhang, et al.. (2022). Design, Synthesis, and Biological Evaluation of [1,2,4]triazolo[4,3-a] Pyrazine Derivatives as Novel Dual c-Met/VEGFR-2 Inhibitors. Frontiers in Chemistry. 10. 815534–815534. 12 indexed citations
6.
Ye, Xinyue, Ya Huang, Chenyu Zhou, et al.. (2021). MSI-1 combats drug-resistant S. aureus by affecting bacterial viability and inhibiting carotenoid pigment production. Microbiological Research. 255. 126909–126909. 16 indexed citations
7.
Bai, Zhaoshi, Yiran Zhou, Xinyue Ye, et al.. (2021). Survivin suppression heightens BZML-induced mitotic catastrophe to overcome multidrug resistance by removing therapy-induced senescent A549/Taxol cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1869(2). 119174–119174. 7 indexed citations
8.
Huang, Bo, Zhaoshi Bai, Xinyue Ye, et al.. (2021). Structural analysis and binding sites of inhibitors targeting the CD47/SIRPα interaction in anticancer therapy. Computational and Structural Biotechnology Journal. 19. 5494–5503. 13 indexed citations
9.
Bai, Zhaoshi, et al.. (2021). QTMP, a Novel Thiourea Polymer, Causes DNA Damage to Exert Anticancer Activity and Overcome Multidrug Resistance in Colorectal Cancer Cells. Frontiers in Oncology. 11. 667689–667689. 2 indexed citations
10.
Bai, Zhaoshi, Xiaolin Liu, Qi Guan, et al.. (2019). 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells. Chemico-Biological Interactions. 315. 108886–108886. 14 indexed citations
11.
Yu, Qian, Qidi Ying, Xin Xie, et al.. (2019). Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment. Cell Death and Disease. 10(3). 218–218. 77 indexed citations
12.
Bai, Zhaoshi, Huijuan Zhang, Qi Guan, et al.. (2017). BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe. Cancer Letters. 402. 81–92. 64 indexed citations
13.
14.
Feng, Dongjie, Yue Wu, Hao Wang, et al.. (2017). Synthesis and antiproliferative activity of 2-aryl-4-(3,4,5-trimethoxybenzoyl)-1,2,3-triazol derivatives as microtubule-destabilizing agents. RSC Advances. 7(46). 29103–29111. 12 indexed citations
15.
Sun, Maolin, Zhaoshi Bai, Yueting Wang, et al.. (2017). Design, synthesis and bioevaluation of antitubulin agents carrying diaryl-5,5-fused-heterocycle scaffold. European Journal of Medicinal Chemistry. 139. 242–249. 16 indexed citations
16.
Xu, Jingwen, Mengting Han, Jiwei Shen, et al.. (2016). 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol inhibits MDM2 and induces apoptosis in breast cancer cells through a p53-independent pathway. Cancer Letters. 383(1). 9–17. 23 indexed citations
17.
Xu, Jingwen, Daiying Zuo, Huan Qi, et al.. (2016). 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ0814061), a novel microtubule inhibitor, evokes G2/M cell cycle arrest and apoptosis in human breast cancer cells. Biomedicine & Pharmacotherapy. 78. 308–321. 25 indexed citations
18.
Yang, Lei, Ju Wang, Weihua Jiang, et al.. (2016). Doxorubicin conjugated functionalizable carbon dots for nucleus targeted delivery and enhanced therapeutic efficacy. Nanoscale. 8(12). 6801–6809. 146 indexed citations
19.
Wen, Zhiyong, Jingwen Xu, Huan Qi, et al.. (2014). 3-(3,4,5-Trimethoxyphenylselenyl)-1H-indoles and their selenoxides as combretastatin A-4 analogs: Microwave-assisted synthesis and biological evaluation. European Journal of Medicinal Chemistry. 90. 184–194. 146 indexed citations
20.
Qi, Huan, Daiying Zuo, Zhaoshi Bai, et al.. (2014). COH-203, a novel microtubule inhibitor, exhibits potent anti-tumor activity via p53-dependent senescence in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 455(3-4). 262–268. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maha Abdulla Breakdown of academic impact, for papers by Arindam Talukdar Breakdown of academic impact, for papers by Dipon Das Breakdown of academic impact, for papers by Dejene Tolossa Debela Breakdown of academic impact, for papers by Merve Erkısa Breakdown of academic impact, for papers by Praveen Sharma Breakdown of academic impact, for papers by Yongsheng Xie Breakdown of academic impact, for papers by Salomão Dória Jorge Breakdown of academic impact, for papers by Yasuyo Suga Breakdown of academic impact, for papers by Matthew L. Brown
Rankless by CCL
2026